Surface
Logix Inc is developing a product pipeline using
our Pharmacomer™ Technology Platform to create
New Chemical Entities (NCEs) with improved
Pharmacokinetic (PK) and or Pharmacodynamic (PD)
properties that address:
- Multiple therapeutic areas
- High unmet medical needs
- Significant commercial opportunities
To learn more about a particular indication,
please select a particular program.
|